Questions about whether acetaminophen use during pregnancy can lead children to develop neurological problems have sparked scientific inquiry and litigation. Lawsuits are continuing, but a new National Institutes of Health-sponsored study has results that show no causal link between acetaminophen and neurodevelopmental disorders.
After experiencing firsthand the shortcomings of existing public and private programs to treat children's developmental delays, Jen Wirt founded a startup called Coral Care. The company, which announced its official launch on Tuesday, brings pediatric developmental specialty care into families’ homes.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Forta Health raised $55 million in Series A funding on Wednesday. The startup offers a platform to help family caregivers quickly access care to manage their loved ones' chronic conditions. Its first area of focus is autism spectrum disorder (ASD).
As an autistic person with chronic illness, I've sat in my car and cried after doctor's appointments where debilitating symptoms were dismissed as anxiety or communication with staff broke down. That’s why as a healthcare executive, I’m working to change that experience for others like me.
Cognoa's Canvas Dx product is authorized by the Food and Drug Administration and assists healthcare providers in diagnosing autism spectrum disorder for children ages 18 months through 72 months. Members of Health Transformation Alliance can now add Canvas Dx to their benefit plans.
The system, developed by digital health startup Cognoa, uses information from questionnaires and videos to help pediatricians diagnose autism. It received marketing authorization from the FDA on Wednesday.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The need and demand for access to quality, interdisciplinary therapy will only continue to grow. Early intervention, with consistent, qualified care provided under one roof, can generate better outcomes that will help children and their families change what autism means in their lives.
Researchers and advocates have convincingly shown that the wide gap in diagnoses between boys and girls isn’t simply a matter of boys being significantly more likely to be on the autism spectrum.
System1 Biosciences' platform combines stem cell lines from patients with brain diseases with a three-dimensional in vitro system and data analytics.
By teaming up, SAP employees will be able to use Cognoa's app to screen their children for developmental delays in language, behavior and other areas.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Q BioMed and Asdera have signed a licensing deal built around a therapeutic intervention for autism spectrum disorder, which seeks to prevent the loss of speech.
Existing Cognoa investor Morningside, a private equity and venture capital firm, provided the new funding.
Anthem has joined the trend of major corporations, including accounting firm EY and Microsoft, hiring workers on the autism spectrum for their cognitive abilities and other strengths, such as focus.
A new hormonal medication appears to be more effective if used intranasally instead of orally and intravenously, at least for some medical conditions.
CEO and founder of SnugVest, Lisa Fraser described how it created a business around the concept of using air pressure, instead of weight, for a line of vests used to calm those with autism.